SELL and neoplasm: A potential candidate is the peripheral node addressin (PNAd), an L-selectin ligand normally only expressed in secondary lymphoid tissues but found to be aberrantly expressed on the endothelium in 11 of 18 melanoma primary tumours,45 which can interact with monocytes and neutrophils expressing L-selectin.